FIELD: biotechnology.
SUBSTANCE: group of inventions relates to biotechnology. A method for protecting piglets from Streptococcus suis pathogenic infection is presented, which provides for the introduction of a vaccine containing an immunologically effective amount of antigen based on Streptococcus suis IgM protease and its use. In this case, the vaccine is administered only once, and the vaccine contains a maximum of no more than 120 micrograms of antigen per dose.
EFFECT: invention makes it possible to obtain a highly effective method for combating the pathogenic infection of Streptococcus suis when using small doses of the vaccine and its single administration.
7 cl, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS | 2018 |
|
RU2769573C2 |
| VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS | 2019 |
|
RU2802072C2 |
| COMBINED VACCINE | 2019 |
|
RU2777065C1 |
| VACCINATION AGAINST PORCINE CIRCOVIRUSES | 2019 |
|
RU2798442C2 |
| NEW HAEMOPHILUS PARASUIS VACCINE | 2020 |
|
RU2822516C1 |
| Lawsonia-BASED VACCINE AND METHODS OF ITS APPLICATION | 2006 |
|
RU2420310C2 |
| PORCINE CIRCOVIRUS TYPE 2 VACCINE | 2014 |
|
RU2712155C2 |
| METHOD FOR PREPARING A READY-TO-USE COMBINED PCV2 / MYCOPLASMA HYOPNEUMONIAE VACCINE | 2015 |
|
RU2731845C2 |
| VACCINE AGAINST LAWSONIA INTRACELLULARIS AND PORCINE CIRCOVIRUS 2 | 2014 |
|
RU2672251C1 |
| POLYVALENT INACTIVATED VACCINE AGAINST SWINE STREPTOCOCCOSIS, METHOD FOR ITS PRODUCTION AND USE | 2021 |
|
RU2761379C1 |
